AH

Apeiron Holdings Limited

North America, Massachusetts, United States, Boston

Description

Apeiron Holdings Limited is a private investment office founded to leverage investment opportunities of its affiliate Apeiron Partners.

Investor Profile

Apeiron Holdings Limited has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Apeiron Holdings Limited frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Negev Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 1
Noetic Fund
North America, Ontario, Canada, Toronto
Co-Investments: 1
BC
North America, California, United States, Santa Monica
Co-Investments: 1
OMX Ventures
North America, Illinois, United States, Lincolnshire
Co-Investments: 1
PS
North America, Illinois, United States, Highland Park
Co-Investments: 1
Casa Verde Capital
North America, California, United States, Los Angeles
Co-Investments: 1
OP
North America, NA - Puerto Rico, Puerto Rico, San Juan
Co-Investments: 1

What are some of recent deals done by Apeiron Holdings Limited?

Delix Therapeutics

Boston, Massachusetts, United States

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

BiotechnologyHealth CareLife Science
Series ASep 27, 2021
Amount Raised: $70,000,000
EnBiotix

Cambridge, Massachusetts, United States

EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.

BiotechnologyHealth CarePharmaceutical
Series AMay 12, 2016

Find More Investors Like Apeiron Holdings Limited

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Apeiron Holdings Limited | Pipeseed